General MedicationsORALGeneric

TALACEN

ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE

Standard Dose

650MG;EQ 25MG BASE

Max Dose

Refer to approved labeling

Primary Use

Review priority: STANDARD Marketing status: Discontinued

Summary

Approval overview TALACEN is listed in Drugs@FDA under application 018458 (NDA).

Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE Form and strength TABLET;ORAL - 650MG;EQ 25MG BASE Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2011-06-22 00:00:00.

Structured Monograph

Clinical summary

Approval overview TALACEN is listed in Drugs@FDA under application 018458 (NDA). Review priority: STANDARD Marketing status: Discontinued Active ingredient ACETAMINOPHEN; PENTAZOCINE HYDROCHLORIDE Form and strength TABLET;ORAL - 650MG;EQ 25MG BASE Sponsor SANOFI AVENTIS US Submission history Latest submission status date: 2011-06-22 00:00:00. Submission type: SUPPL.

Monitoring

• Marketing status: Discontinued
• Review priority: STANDARD

Interaction Notes

No interaction notes stored yet.